Table 3 Metabolic pathways differentially expressed accross lactation stages (21 vs. 180 days in milk; DIM) or by genetic strains (North American Holstein vs. New Zealand Holstein; NAH vs. NAZ) at 21 days in milk. Total compounds, hits and pathway impacts are presented along with P-statistics.

From: Plasma concentrations of branched-chain amino acids differ with Holstein genetic strain in pasture-based dairy systems

 

Metabolic pathways

Total comp1

Hits\(^2\)

raw-P\(^3\)

FDR\(^3\)

Impact\(^4\)

a. 21 vs. 180 DIM

AA and protein

Phenylalanine metabolism

12

6

4.3E-08

7.6E-07

0.60

AA and protein

Arginine biosynthesis

14

8

4.6E-08

7.6E-07

0.41

AA and protein

Arginine and proline metabolism

38

6

5.2E-08

7.6E-07

0.36

AA and protein

Tyrosine metabolism

42

4

1.1E-07

1.3E-06

0.16

AA and protein

Histidine metabolism

16

3

3.1E-07

3.0E-06

0.22

AA and protein

Alanine, aspartate and glutamate metabolism

28

11

8.7E-07

7.2E-06

0.67

AA and protein

\(\beta \)-Alanine metabolism

21

5

1.3E-06

9.1E-06

0.50

AA and protein

Glycine, serine and threonine metabolism

34

8

3.9E-06

1.9E-05

0.52

AA and protein

Cysteine and methionine metabolism

33

8

4.6E-06

1.9E-05

0.50

AA and protein

Tryptophan metabolism

41

4

4.9E-06

1.9E-05

0.25

AA and protein

Lysine degradation

25

3

5.6E-06

2.0E-05

0.14

AA and protein

Phenylalanine, tyrosine and tryptophan biosynthesis

4

2

9.3E-06

2.8E-05

1.00

AA and protein

Aminoacyl-tRNA biosynthesis

48

19

9.5E-06

2.8E-05

0.17

AA and protein

Taurine and hypotaurine metabolism

8

1

2.0E-05

5.0E-05

0.00

AA and protein

Thiamine metabolism

7

1

2.0E-05

5.0E-05

0.00

AA and protein

D-Glutamine and D-glutamate metabolism

5

3

4.4E-05

9.2E-05

1.00

AA and protein

Valine, leucine and isoleucine biosynthesis

8

6

9.2E-04

1.5E-03

0.00

AA and protein

Valine, leucine and isoleucine degradation

40

4

6.4E-03

9.3E-03

0.01

AA and protein

Nitrogen metabolism

6

2

6.6E-03

9.4E-03

0.00

Carbohydrates

Glyoxylate and dicarboxylate metabolism

32

9

4.5E-06

1.9E-05

0.28

Carbohydrates

Fructose and mannose metabolism

20

2

1.3E-04

2.4E-04

0.03

Carbohydrates

Galactose metabolism

27

10

1.7E-04

3.1E-04

0.29

Carbohydrates

Pentose and glucuronate interconversions

18

6

4.0E-04

7.0E-04

0.50

Carbohydrates

Amino sugar and nucleotide sugar metabolism

37

5

5.0E-03

7.5E-03

0.11

Energy central

Citrate cycle (TCA cycle)

20

7

8.4E-06

2.7E-05

0.35

Energy central

Propanoate metabolism

23

4

3.8E-05

8.1E-05

0.04

Energy central

Butanoate metabolism

15

6

9.8E-05

1.9E-04

0.03

Energy central

Ubiquinone and other terpenoid-quinone biosynthesis

9

1

4.2E-04

7.2E-04

0.00

Energy central

Biotin metabolism

10

1

7.4E-04

1.2E-03

0.00

Energy central

Glycolysis / Gluconeogenesis

26

1

1.7E-02

2.4E-02

0.10

Energy central

Synthesis and degradation of ketone bodies

5

1

2.1E-02

2.9E-02

0.00

Energy central

Pentose phosphate pathway

22

3

3.2E-02

4.1E-02

0.05

Heme biosynthesis

Porphyrin and chlorophyll metabolism

30

2

2.3E-03

3.5E-03

0.00

Lipid

Fatty acid biosynthesis

47

4

2.5E-06

1.6E-05

0.01

Lipid

Arachidonic acid metabolism

37

1

3.1E-06

1.8E-05

0.32

Lipid

Fatty acid elongation

39

1

4.1E-06

1.9E-05

0.00

Lipid

Linoleic acid metabolism

5

1

1.4E-05

3.9E-05

1.00

Lipid

Biosynthesis of unsaturated fatty acids

36

6

2.1E-05

5.0E-05

0.00

Lipid

Fatty acid degradation

39

2

2.2E-05

5.2E-05

0.00

Lipid

Primary bile acid biosynthesis

46

3

4.8E-05

9.5E-05

0.06

Lipid

Glycerolipid metabolism

16

2

1.5E-03

2.4E-03

0.33

Lipid

Inositol phosphate metabolism

30

4

3.3E-02

4.2E-02

0.16

Nitrogenous bases

Purine metabolism

66

4

3.3E-05

7.3E-05

0.02

Redox

Glutathione metabolism

28

5

1.0E-08

5.8E-07

0.12

Redox

Ascorbate and aldarate metabolism

10

4

2.2E-02

2.9E-02

0.50

Vitamins and coenzymes

Pantothenate and CoA biosynthesis

19

7

6.0E-06

2.0E-05

0.06

Lipid

Steroid hormone biosynthesis

75

1

5.8E-02

7.2E-02

0.01

Anitbiotic biosynthesis

Neomycin, kanamycin and gentamicin biosynthesis

2

2

6.9E-02

8.3E-02

0.00

b. NAH vs. NZH cows at early lactation (21 DIM)

AA and protein

Valine, leucine and isoleucine degradation

40

4

6.8E-04

2.2E-02

0.01

AA and protein

Valine, leucine and isoleucine biosynthesis

8

6

7.7E-04

2.2E-02

0.00

AA and protein

Lysine degradation

25

3

1.2E-03

2.2E-02

0.14

Redox

Selenocompound metabolism

20

1

3.8E-03

5.5E-02

0.00

AA and protein

Aminoacyl-tRNA biosynthesis

48

19

6.0E-03

6.9E-02

0.17

  1. 1: Total metabolites theoretically considered by the Bos taurus KEGG database for the current metabolic pathways.
  2. 2: Metabolites efectively quantified in the current study and belonging to the identified pathway.
  3. 3: Raw-P and FDR-adjusted P values obtained with the Global Test.
  4. 4: Topological analysis of impact of the current metabolic pathway.